Empagliflozin alleviates myocardial I/R injury and cardiomyocyte apoptosis via inhibiting ER stress-induced autophagy and the PERK/ATF4/Beclin1 pathway-Reference-Cited by-同舟云学术

Empagliflozin alleviates myocardial I/R injury and cardiomyocyte apoptosis via inhibiting ER stress-induced autophagy and the PERK/ATF4/Beclin1 pathway

Published:2022-05-12 Issue:8 Volume:30 Page:858-872
ISSN:1061-186X
Container-title:Journal of Drug Targeting
language:en
Short-container-title:Journal of Drug Targeting

Author:

Wang Cuan-Cuan¹,Li Ying¹,Qian Xiao-Qian¹,Zhao Hui¹,Wang Dong¹,Zuo Guo-Xing¹,Wang Kuan¹

Affiliation:

1. Department of Cardiology, Tianjin Fifth Central Hospital, Tianjin, China

Funder

Tianjin Health Commission

Publisher

Informa UK Limited

Subject

Pharmaceutical Science

Link

https://www.tandfonline.com/doi/pdf/10.1080/1061186X.2022.2064479

Reference48 articles.

1. Mortality From Ischemic Heart Disease

2. Estimating Deaths From Cardiovascular Disease: A Review of Global Methodologies of Mortality Measurement

3. Myocardial ischemia: Current concepts and future perspectives

4. The Pathophysiology of Myocardial Ischemia and Perioperative Myocardial Infarction

5. Myocardial ischemia-reperfusion injury: a neglected therapeutic target

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardioprotection of Canagliflozin, Dapagliflozin, and Empagliflozin: Lessons from preclinical studies;Chemico-Biological Interactions;2024-11

2. SGLT2 inhibitors: how do they affect the cardiac cells;Molecular and Cellular Biochemistry;2024-08-19

3. Targeting translocator protein protects against myocardial ischemia/reperfusion injury by alleviating mitochondrial dysfunction;Experimental and Therapeutic Medicine;2024-07-04

4. Is There a Role for SGLT2 Inhibitors in Patients with End-Stage Kidney Disease?;Current Hypertension Reports;2024-06-24

5. Cardiovascular outcomes and molecular targets for the cardiac effects of Sodium-Glucose Cotransporter 2 Inhibitors: A systematic review;Biomedicine & Pharmacotherapy;2024-06